Go
HomeASCP FoundationCCGPCalendarDiscussionContactStore
Join ASCP Earn CE Credit Develop Your Practice Explore Policy Issues Read All About It
About ASCP
Education & Meetings
Practice Resources
Government Affairs & Advocacy
Publications
Members
Students
Industry
Public
spacer
ASCP 40th Anniversary
spacer
ASCP on Twitter ASCP on Facebook ASCP on LinkedIn
spacer
Monitor-Rx
Advanced SearchSite Map
Government Affairs & Advocacy Section
Government Affairs & Advocacy Section picture
spacer
spacer
ASCP Annual Meeting and Exhibition 2010
spacer
Easy Prior Authorizations
spacer
QCCPP
spacer
Addressing Barriers to Optimal Care of Patients with MDD and GAD in the Long-Term Care Setting: The Pharmacy Perspective
spacer
SeniorCarePharmacist.com
Omnicare v. Prime Therapeutics
Arbitrator Rules that LTC Pharmacy has No BAE Obligation;  Awards $554,281 for Unpaid Co-pay Claims.
 
An arbitrator has ruled that Prime Therapeutics, a Pharmacy Benefit Manager under contract to several Part D plans must pay Omnicare $554,281 for improperly adjudicated co-payments. The arbitration found that Omnicare had properly submitted the co-payment claims to Prime and had not collected the co-payments from low-income beneficiaries.  The arbitrator rejected Prime Therapeutics defense that Omnicare had not submitted “Best Available Evidence” and therefore was not entitled to payment. The arbitrator ruled, that under the terms of the contract between the parties, Omnicare had no obligations to collect BAE in order to be paid. Prime Therapeutics has asked a Federal Court to vacate the arbitrator’s ruling. A decision on Prime Therapeutics Motion to Vacate is expected in about one month.

For a copy of the decision please click here.
Print PagePrint Page  Email PageEmail Page 
Copyright & DisclaimerPrivacy StatementGuidelines
#Email Address